Literature DB >> 25845498

GPR4 decreases B16F10 melanoma cell spreading and regulates focal adhesion dynamics through the G13/Rho signaling pathway.

Calvin R Justus1, Li V Yang2.   

Abstract

The effect of acidosis, a biochemical hallmark of the tumor microenvironment, on cancer progression and metastasis is complex. Both pro- and anti-tumorigenic effects of acidosis have been reported and the acidic microenvironment has been exploited for specific delivery of drugs, imaging agents, and genetic constructs into tumors. In this study we investigate the spreading and focal adhesion of B16F10 melanoma cells that are genetically engineered to overexpress the pH-sensing G protein-coupled receptor GPR4. By using cell attachment assays we found that GPR4 overexpression delayed cell spreading and altered the spatial localization of dynamic focal adhesion complex, such as the localization of phosphorylated focal adhesion kinase (FAK) and paxillin, at acidic pH. The potential G-protein and downstream signaling pathways that are responsible for these effects were also investigated. By using the Rho inhibitor CT04 (C3 transferase), the Rho-associated kinase (ROCK) inhibitors Y27632 and thiazovivin, the myosin light chain kinase (MLCK) inhibitor staurosporine or a G12/13 inhibitory construct, cell spreading was restored whereas the inhibition and activation of the Gq and Gs pathways had little or no effect. Altogether our results indicate that through the G12/13/Rho signaling pathway GPR4 modulates focal adhesion dynamics and reduces cell spreading and membrane ruffling.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acidosis; Cell spreading; Focal adhesion; GPR4; Tumor microenvironment

Mesh:

Substances:

Year:  2015        PMID: 25845498     DOI: 10.1016/j.yexcr.2015.03.022

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

Review 1.  Proton-sensing G protein-coupled receptors: detectors of tumor acidosis and candidate drug targets.

Authors:  Paul A Insel; Krishna Sriram; Cristina Salmerón; Shu Z Wiley
Journal:  Future Med Chem       Date:  2020-03-02       Impact factor: 3.808

2.  pH and proton-sensitive receptors in brain ischemia.

Authors:  Xiang-Ming Zha; Zhi-Gang Xiong; Roger P Simon
Journal:  J Cereb Blood Flow Metab       Date:  2022-03-18       Impact factor: 6.960

3.  S-Geranylgeranyl-L-glutathione is a ligand for human B cell-confinement receptor P2RY8.

Authors:  Erick Lu; Finn D Wolfreys; Jagan R Muppidi; Ying Xu; Jason G Cyster
Journal:  Nature       Date:  2019-03-06       Impact factor: 49.962

Review 4.  Role of Sphingosylphosphorylcholine in Tumor and Tumor Microenvironment.

Authors:  Mi Kyung Park; Chang Hoon Lee
Journal:  Cancers (Basel)       Date:  2019-10-31       Impact factor: 6.639

5.  The Proton-Sensing GPR4 Receptor Regulates Paracellular Gap Formation and Permeability of Vascular Endothelial Cells.

Authors:  Elizabeth A Krewson; Edward J Sanderlin; Mona A Marie; Shayan Nik Akhtar; Juraj Velcicky; Pius Loetscher; Li V Yang
Journal:  iScience       Date:  2020-01-17

6.  Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.

Authors:  Minhao Yu; Ran Cui; Yizhou Huang; Yang Luo; Shaolan Qin; Ming Zhong
Journal:  EBioMedicine       Date:  2019-09-14       Impact factor: 8.143

7.  Decreased extracellular pH inhibits osteogenesis through proton-sensing GPR4-mediated suppression of yes-associated protein.

Authors:  Shi-Cong Tao; You-Shui Gao; Hong-Yi Zhu; Jun-Hui Yin; Yi-Xuan Chen; Yue-Lei Zhang; Shang-Chun Guo; Chang-Qing Zhang
Journal:  Sci Rep       Date:  2016-06-03       Impact factor: 4.379

8.  Contextual tumor suppressor function of T cell death-associated gene 8 (TDAG8) in hematological malignancies.

Authors:  Calvin R Justus; Edward J Sanderlin; Lixue Dong; Tianai Sun; Jen-Tsan Chi; Kvin Lertpiriyapong; Li V Yang
Journal:  J Transl Med       Date:  2017-10-10       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.